Group 1 - The personal care products sector increased by 1.77% on January 20, with Yanjiang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 4113.65, down 0.01%, while the Shenzhen Component Index closed at 14155.63, down 0.97% [1] - Key stocks in the personal care sector showed varied performance, with Yanjiang Co., Ltd. closing at 19.40, up 9.11%, and Ziya Co., Ltd. at 22.51, up 4.16% [1] Group 2 - The personal care products sector experienced a net outflow of 47.99 million yuan from institutional investors, while retail investors saw a net inflow of 9.42 million yuan [2] - The trading volume for Yanjiang Co., Ltd. was 638,400 shares, with a total transaction value of 1.257 billion yuan [1] - The stock performance of major companies included a 2.51% increase for Beijia Co. and a 2.25% increase for Dengkang Oral Care [1][2] Group 3 - The net inflow from retail investors for the stock of Yiyi Co. was 400.92 million yuan, while the net outflow from institutional investors was 595.82 million yuan for Kela Co. [3] - The net inflow for Ziya Co. was 299.34 million yuan from retail investors, while it faced a net outflow of 1,407.33 million yuan from institutional investors [3] - The overall market sentiment showed mixed results, with some stocks like Yiyi Co. and Beijia Co. attracting retail interest despite institutional outflows [3]

Summary of Baia Co., Ltd. Conference Call Company Overview - **Company**: Baia Co., Ltd. - **Focus**: E-commerce performance and strategic adjustments for 2026 Key Points 1. 2026 E-commerce Performance - The company anticipates a significant reduction in losses for 2026 due to internal reflections and strategic corrections made after substantial losses in 2025 [1] - Adjustments include personnel changes aimed at improving profitability in the e-commerce segment [1] 2. Impact of E-commerce Slowdown - Concerns were raised about whether the slowdown in e-commerce would disrupt the company's operational logic [1] - Historically, e-commerce has played a crucial role in driving product popularity and offline traffic [1] - For 2026, the company will continue to focus on its PRO, organic cotton, and pants series, which are expected to maintain a solid flow of customers [1] 3. Expansion into New Provinces - The company has successfully completed its expansion into approximately 10 new provinces beyond its original five [1] - Future market share growth in these new provinces will increasingly depend on the effectiveness of the offline sales team [1] 4. Shift in Resource Allocation - Following the slowdown in e-commerce, the company plans to allocate more resources to offline operations [1] - National expansion is identified as the core driver of growth for the next 3-5 years [1] 5. Growth Rate Concerns - There are questions regarding whether the company will face a slowdown in growth due to the e-commerce decline [1] Additional Insights - The company is committed to enhancing its profitability and operational efficiency in response to market challenges [1] - The strategic focus on offline expansion indicates a shift in business model to adapt to changing market conditions [1]

Core Viewpoint - The personal care products sector experienced a 1.96% increase on January 19, with Yanjiang Co., Ltd. leading the gains, while the Shanghai Composite Index rose by 0.29% and the Shenzhen Component Index increased by 0.09% [1] Group 1: Market Performance - The closing price of Yanjiang Co., Ltd. was 17.78, reflecting a significant increase of 19.97% with a trading volume of 767,100 shares and a transaction value of 1.28 billion yuan [1] - Baiya Co., Ltd. closed at 21.61, up by 4.60%, with a trading volume of 130,400 shares and a transaction value of 283 million yuan [1] - Reliable Co., Ltd. saw a closing price of 13.46, increasing by 2.12% with a trading volume of 32,300 shares [1] Group 2: Fund Flow Analysis - The personal care products sector had a net outflow of 50.30 million yuan from institutional investors, while retail investors saw a net inflow of 17.49 million yuan [2] - The main funds showed a net inflow of 7.99 million yuan into Stable Medical, while the retail funds had a net outflow of 16.41 million yuan [3] - In contrast, Jingya Co., Ltd. experienced a net outflow of 3.24 million yuan from main funds, but retail funds showed a net inflow of 5.23 million yuan [3]

Investment Rating - The report maintains a "Buy" rating for the company [3][6] Core Insights - The company plans to acquire Hebei Kangda for a maximum of 450 million RMB, aiming to enhance its performance and strengthen its presence in the northern home care market [1][2] - The acquisition is expected to create synergies between the existing home care business and Hebei Kangda, which has over 30 years of experience in the northern market [3][9] - The company is projected to achieve revenue of 1.996 billion RMB in 2025, 2.397 billion RMB in 2026, and 2.611 billion RMB in 2027, with year-on-year growth rates of 9.7%, 20.1%, and 9.0% respectively [3][5] - The net profit attributable to the parent company is expected to be 223 million RMB in 2025, 268 million RMB in 2026, and 294 million RMB in 2027, with growth rates of 9.8%, 20.2%, and 9.4% respectively [3][5] Financial Summary - The company’s revenue for 2023 is reported at 1,616 million RMB, with a year-on-year growth of 12.0% [5][10] - The net profit for 2023 is 175 million RMB, showing a significant year-on-year increase of 170.4% [5][10] - The projected earnings per share (EPS) for 2025 is 0.17 RMB, increasing to 0.20 RMB in 2026 and 0.22 RMB in 2027 [5][10] - The current market capitalization is approximately 3.25 billion HKD, with a total share count of 1.33 billion shares [6][10]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook on its stock performance [3][6]. Core Insights - The company plans to acquire Hebei Kangda for a maximum of 450 million RMB, aiming to enhance its market presence in the northern home care market and improve competitiveness [1][2]. - The acquisition is expected to increase revenue and profit, leveraging brand synergy and category share to achieve multi-dimensional collaborative effects [2][3]. - The company is positioned as a leader in the home care segment, with a robust multi-brand and multi-category strategy, focusing on both online growth platforms and offline expansion [3]. Financial Projections - Revenue projections for 2025-2027 are estimated at 1,996 million RMB, 2,397 million RMB, and 2,611 million RMB, reflecting year-on-year growth rates of 9.7%, 20.1%, and 9.0% respectively [3][5]. - Net profit estimates for the same period are 223 million RMB, 268 million RMB, and 294 million RMB, with corresponding growth rates of 9.8%, 20.2%, and 9.4% [3][5]. - The current market capitalization corresponds to a PE ratio of 11 times for 2026 [3]. Strategic Acquisition Details - Hebei Kangda has over 30 years of experience in the northern market, specializing in home insecticides and cleaning products, which will enhance the company's resource integration and operational efficiency post-acquisition [9]. - The acquisition is anticipated to solidify the company's market position in household insecticides and cleaning products, thereby reinforcing its leadership in the industry [9]. - Financially, Hebei Kangda reported a revenue of 468 million RMB in 2024, with a net profit of 86 million RMB, indicating strong financial health that will contribute positively to the acquiring company [9].

Core Viewpoint - The personal care products sector experienced a decline of 1.72% on January 15, with a notable drop in the stock of Wanjian Medical, while the overall market showed mixed results with the Shanghai Composite Index down 0.33% and the Shenzhen Component Index up 0.41% [1] Group 1: Market Performance - The personal care products sector's decline was led by Wanjian Medical, which fell by 3.57% to a closing price of 38.08 [2] - The Shanghai Composite Index closed at 4112.6, down 0.33%, while the Shenzhen Component Index closed at 14306.73, up 0.41% [1] Group 2: Individual Stock Performance - Notable stock performances included: - Dengkang Oral (001328) rose by 2.51% to 41.27 with a trading volume of 28,300 shares and a transaction value of 116 million [1] - Other stocks such as Zhongshun Jierou (002511) and Liangmian Needle (600249) saw minor declines of 0.24% and 0.51% respectively [1] - The largest decline was observed in Wanjian Medical (300888), which dropped by 3.57% [2] Group 3: Capital Flow - The personal care products sector saw a net inflow of 531,700 yuan from institutional investors, while retail investors experienced a net outflow of 2,407,430 yuan [2] - The capital flow for individual stocks indicated that Wanjian Medical had a net inflow of 21,931,300 yuan from institutional investors, but a significant outflow of 45,204,800 yuan from retail investors [3]

Core Viewpoint - The personal care products sector experienced a slight increase of 0.2% on January 14, with Baiya Co., Ltd. leading the gains, while the Shanghai Composite Index fell by 0.31% and the Shenzhen Component Index rose by 0.56% [1]. Group 1: Market Performance - The closing price of Baiya Co., Ltd. was 21.24, with an increase of 1.09% and a trading volume of 77,000 shares, amounting to a transaction value of 163 million yuan [1]. - Other notable performers included Yiyi Co., Ltd. with a closing price of 28.72 and a rise of 1.06%, and Haoyue Care with a closing price of 32.78 and an increase of 1.02% [1]. - Conversely, companies like Jiya Co., Ltd. and Wanjian Medical saw slight declines of 0.19% and 0.23%, respectively [1]. Group 2: Capital Flow - The personal care products sector saw a net inflow of 4.32 million yuan from institutional investors, while retail investors experienced a net outflow of 7.12 million yuan [2]. - The capital flow data indicates that Yiyi Co., Ltd. had a significant net inflow of 13.31 million yuan from institutional investors, while it faced a net outflow of 6.19 million yuan from retail investors [3]. - Other companies like Haoyue Care and Dongkang Oral also showed mixed capital flows, with institutional inflows but retail outflows [3].

Market Overview - The personal care products sector experienced a slight decline of 0.03% on January 13, with Baiya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 4138.76, down 0.64%, while the Shenzhen Component Index closed at 14169.4, down 1.37% [1] Stock Performance - Notable gainers in the personal care sector included: - Dengkang Oral Care (001328) with a closing price of 40.60, up 6.17% [1] - Beijia Clean (603059) with a closing price of 36.25, up 3.93% [1] - Jieya Co., Ltd. (301108) with a closing price of 35.95, up 3.72% [1] - Other stocks showed mixed performance, with some experiencing declines, such as: - Two-Sided Needle (600249) down 0.67% to 5.92 [1] - Zhongshun Jiesang (002511) down 0.95% to 8.32 [1] Capital Flow - The personal care products sector saw a net inflow of 17.19 million yuan from institutional investors, while retail investors experienced a net outflow of 20.21 million yuan [2] - The capital flow for individual stocks indicated that: - Reliable Co., Ltd. (301009) had a net inflow of 10.73 million yuan from institutional investors [3] - Beijia Clean (603059) faced a net outflow of 3.99 million yuan from institutional investors [3]

Market Overview - The personal care products sector increased by 1.28% on January 12, with Beijia leading the gains [1] - The Shanghai Composite Index closed at 4165.29, up by 1.09%, while the Shenzhen Component Index closed at 14366.91, up by 1.75% [1] Stock Performance - Beijia (603059) closed at 34.88, with a rise of 10.00% and a trading volume of 21,500 lots, resulting in a transaction value of 74.26 million yuan [1] - Haoyue Care (605009) closed at 32.52, up by 2.59%, with a trading volume of 38,600 lots and a transaction value of 124 million yuan [1] - Reliable Co. (301009) closed at 13.11, increasing by 1.55%, with a trading volume of 47,100 lots and a transaction value of 61.36 million yuan [1] - Other notable stocks include: - Wenjian Medical (300888) at 39.73, up by 1.43% [1] - Runben Co. (603193) at 25.33, up by 1.40% [1] - Liangmian Needle (600249) at 5.96, up by 1.36% [1] Capital Flow - The personal care products sector experienced a net outflow of 1.1334 million yuan from institutional investors, while retail investors saw a net inflow of 5.4803 million yuan [2] - The overall capital flow indicates that while institutional investors withdrew funds, retail investors were actively buying into the sector [2] Detailed Capital Flow Analysis - Beijia (603059) had a net inflow of 23.84 million yuan from institutional investors, but a net outflow of 9.50 million yuan from speculative funds [3] - Haoyue Care (605009) saw a net inflow of 18.45 million yuan from institutional investors, with a net outflow of 12.29 million yuan from speculative funds [3] - Reliable Co. (301009) experienced a net outflow of 5.92 million yuan from institutional investors, while retail investors contributed a net inflow of 6.46 million yuan [3]

Market Overview - The personal care products sector increased by 0.64% on January 9, with Dengkang Oral leading the gains [1] - The Shanghai Composite Index closed at 4120.43, up 0.92%, while the Shenzhen Component Index closed at 14120.15, up 1.15% [1] Stock Performance - Key stocks in the personal care sector showed varied performance, with Dengkang Oral closing at 39.19, up 1.79% on a trading volume of 15,000 shares and a transaction value of 58.84 million yuan [1] - Other notable performers included: - Zhongshun Jierou at 8.38, up 1.09%, with a trading volume of 164,500 shares and a transaction value of 137 million yuan [1] - Wanjian Medical at 39.17, up 1.03%, with a transaction value of 166 million yuan [1] - Liangmian Needle at 5.88, up 1.03%, with a trading volume of 119,500 shares and a transaction value of 69.76 million yuan [1] Capital Flow - The personal care products sector experienced a net outflow of 9.1265 million yuan from institutional investors and 14.5833 million yuan from speculative funds, while retail investors saw a net inflow of 23.7098 million yuan [2] - Detailed capital flow for specific stocks included: - Runben Co. with a net inflow of 4.5229 million yuan from institutional investors, but a net outflow of 6.0816 million yuan from speculative funds [3] - Yiyi Co. had a net outflow of 51,000 yuan from institutional investors, but a net inflow of 619.27 million yuan from retail investors [3] - Dengkang Oral saw a net outflow of 1.5334 million yuan from institutional investors [3]